DIN 02510200 — ONUREG 300 MG
ONUREG is a tablet of Azacitidine marketed by BRISTOL-MYERS SQUIBB CANADA. The full Azacitidine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02510200
- Brand name
- ONUREG
- Active ingredient
- Azacitidine
- Strength
- 300 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Health Canada status
- MARKETED
- Drug class
- Pyrimidine nucleoside analogue / DNA hypomethylating agent (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Azacitidine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02462826 | AZACITIDINE FOR INJECTION | 100 MG | POWDER FOR SUSPENSION | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02501791 | AZACITIDINE FOR INJECTION | 100 MG | POWDER FOR SUSPENSION | JAMP PHARMA CORPORATION | DORMANT |
| 02505177 | AZACITIDINE FOR INJECTION | 100 MG | POWDER FOR SUSPENSION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02507668 | AZACITIDINE FOR INJECTION | 100 MG | POWDER FOR SUSPENSION | HIKMA CANADA LIMITED | MARKETED |
| 02529599 | AZACITIDINE FOR INJECTION | 100 MG | POWDER FOR SUSPENSION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02510197 | ONUREG | 200 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02336707 | VIDAZA | 100 MG | POWDER FOR SUSPENSION | BRISTOL-MYERS SQUIBB CANADA | MARKETED |